(Q36840568)

English

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

oligodendroglioma

1 reference

based on heuristic

inferred from title

anaplastic oligodendroglioma

1 reference

based on heuristic

inferred from title

adult oligodendroglioma

1 reference

based on heuristic

inferred from title

Dominique Figarella-Branger

6

object named as

Dominique Figarella-Branger

0 references

Mathilde Kouwenhoven

3

object named as

Mathilde C Kouwenhoven

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Guido Reifenberger

12

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

10

object named as

Sverre J Mørk

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Johan M Kros

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Thierry Gorlia

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Ping-Pin Zheng

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

V Peter Collins

5

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Felice Giangaspero

7

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Caterina Giannini

8

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Karima Mokhtari

9

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Anders Paetau

11

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Martin J van den Bent

13

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Journal of Neuropathology & Experimental Neurology

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

545-551

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Intraclass correlations: uses in assessing rater reliability

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Subtyping of oligo-astrocytic tumours by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Oligodendroglial neoplasms: current concepts, misconceptions, and folklore

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Oligoastrocytomas: a clinicopathological study of 52 cases.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Oligodendroglioma. A comparison of two grading systems

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000263869.84188.72

21 January 2018

Identifiers

10.1097/01.JNEN.0000263869.84188.72

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36840568&oldid=1881834572"